PDGF-D expression is down-regulated by TGFβ in fibroblasts

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Chaabane, Saima Charni ^a   De Brachéne, Alexandra Coomans ^a   Essaghir, Ahmed ^a   Velghe, Amélie ^a   Re, Sandra Lo ^b   Stockis, Julie ^a   Lucas, Sophie ^a,c   Khachigian, Levon M ^d   Huaux, François ^b   Demoulin, Jean Baptiste ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c Walloon Excellence in Life Sciences and Biotechnology (WELBIO   (Belgium)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D; PROTEIN INHIBITOR; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FIBROBLAST; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG FIBROSIS; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84951980350     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108656     Document Type: Article

References (48)

1. Moustakas A, Heldin CH (2009) The regulation of TGFbeta signal transduction. Development 136: 3699-3714.
2. Wu MY, Hill CS (2009) Tgf-beta superfamily signaling in embryonic development and homeostasis. Developmental cell 16: 329-343.
3. Ikushima H, Miyazono K (2010) TGFbeta signalling: a complex web in cancer progression. Nature reviews Cancer 10: 415-424.
4. Massague J (2008) TGFbeta in Cancer. Cell 134: 215-230.
5. Pardali E, Goumans MJ, ten Dijke P (2010) Signaling by members of the TGFbeta family in vascular morphogenesis and disease. Trends in cell biology 20: 556-567.
6. Li Y, Ge Y, Liu FY, Peng YM, Sun L, et al. (2012) Norcantharidin, a protective therapeutic agent in renal tubulointerstitial fibrosis. Molecular and cellular biochemistry 361: 79-83.
7. Inagaki Y, Higashiyama R, Higashi K (2012) Novel anti-fibrotic modalities for liver fibrosis: molecular targeting and regenerative medicine in fibrosis therapy. Journal of gastroenterology and hepatology 27 Suppl 2: 85-88.
8. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, et al. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270: 2008-2011.
9. Frey RS, Mulder KM (1997) Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer research 57: 628-633.
10. Moustakas A, Heldin CH (2005) Non-Smad TGF-beta signals. Journal of cell science 118: 3573-3584.
11. Delaney JR, Mlodzik M (2006) TGF-beta activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity. Cell cycle 5: 2852-2855.
12. Chow JY, Ban M, Wu HL, Nguyen F, Huang M, et al. (2010) TGF-beta downregulates PTEN via activation of NF-kappaB in pancreatic cancer cells. American journal of physiology Gastrointestinal and liver physiology 298: G275-282.
13. Leeb SN, Vogl D, Falk W, Scholmerich J, Rogler G, et al. (2002) Regulation of migration of human colonic myofibroblasts. Growth factors 20: 81-91.
14. Simm A, Nestler M, Hoppe V (1998) Mitogenic effect of PDGF-AA on cardiac fibroblasts. Basic research in cardiology 93 Suppl 3: 40-43.
15. Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, et al. (2006) Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. Journal of hepatology 45: 419-428.
16. Rice AB, Moomaw CR, Morgan DL, Bonner JC (1999) Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. The American journal of pathology 155: 213-221.
17. Petrov VV, Fagard RH, Lijnen PJ (2002) Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 39: 258-263.
18. Yang D, Qiu D (2005) Linkage between elevated PDGF-C expression and myocardial fibrogenesis in coxsackievirus B3-induced chronic myocarditis. European heart journal 26: 642-643.
19. Zhuo Y, Zhang J, Laboy M, Lasky JA (2004) Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis. American journal of physiology Lung cellular and molecular physiology 286: L182-188.
20. Eitner F, Ostendorf T, Van Roeyen C, Kitahara M, Li X, et al. (2002) Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney. Journal of the American Society of Nephrology: JASN 13: 910-917.
21. Aoyagi Y, Oda T, Kinoshita T, Nakahashi C, Hasebe T, et al. (2004) Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. British journal of cancer 91: 1316-1326.
22. Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, et al. (2005) Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America 102: 3389-3394.
23. Salguero Palacios R, Roderfeld M, Hemmann S, Rath T, Atanasova S, et al. (2008) Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Laboratory investigation; a-journal of technical methods and pathology 88: 1192-1203.
24. Ostendorf T, van Roeyen CR, Peterson JD, Kunter U, Eitner F, et al. (2003) A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. Journal of the American Society of Nephrology: JASN 14: 2237-2247.
25. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE (1989) Effects of plateletderived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. The Journal of clinical investigation 84: 1786-1793.
26. Yamakage A, Kikuchi K, Smith EA, LeRoy EC, Trojanowska M (1992) Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts. The Journal of experimental medicine 175: 1227-1234.
27. Uutela M, Lauren J, Bergsten E, Li X, Horelli-Kuitunen N, et al. (2001) Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes. Circulation 103: 2242-2247.
28. Demoulin JB, Ericsson J, Kallin A, Rorsman C, Ronnstrand L, et al. (2004) Platelet-derived growth factor stimulates membrane lipid synthesis through activation of phosphatidylinositol 3-kinase and sterol regulatory element-binding proteins. The Journal of biological chemistry 279: 35392-35402.
29. Dusa A, Mouton C, Pecquet C, Herman M, Constantinescu SN (2010) JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitors. PloS one 5: e11157.
30. Essaghir A, Dif N, Marbehant CY, Coffer PJ, Demoulin JB (2009) The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors. The Journal of biological chemistry 284: 10334-10342.
31. Liu MY, Eyries M, Zhang C, Santiago FS, Khachigian LM (2006) Inducible platelet-derived growth factor D-chain expression by angiotensin II and hydrogen peroxide involves transcriptional regulation by Ets-1 and Sp1. Blood 107: 2322-2329.
32. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, et al. (1998) Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. The EMBO journal 17: 3091-3100.
33. Pierreux CE, Nicolas FJ, Hill CS (2000) Transforming growth factor betaindependent shuttling of Smad4 between the cytoplasm and nucleus. Molecular and cellular biology 20: 9041-9054.
34. Rabolli V, Lo Re S, Uwambayinema F, Yakoub Y, Lison D, et al. (2011) Lung fibrosis induced by crystalline silica particles is uncoupled from lung inflammation in NMRI mice. Toxicology letters 203: 127-134.
35. Bergsten E, Uutela M, Li X, Pietras K, Ostman A, et al. (2001) PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nature cell biology 3: 512-516.
36. Verrecchia F, Chu ML, Mauviel A (2001) Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. The Journal of biological chemistry 276: 17058-17062.
37. Tripurani SK, Cook RW, Eldin KW, Pangas SA (2012) BMP-specific SMADs function as novel repressors of PDGFA and modulate its expression in ovarian granulosa cells and tumors. Oncogene.
38. Wang S, Wilkes MC, Leof EB, Hirschberg R (2010) Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis. American journal of physiology Renal physiology 298: F142-149.
39. Gingery A, Bradley EW, Pederson L, Ruan M, Horwood NJ, et al. (2008) TGFbeta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Experimental cell research 314: 2725-2738.
40. Cho H, Lee J, Kwak NJ, Lee KH, Rha S, et al. (2003) Silica induces nuclear factor-kappaB activation through TAK1 and NIK in Rat2 cell line. Toxicology letters 143: 323-330.
41. Tan NY, Midgley VC, Kavurma MM, Santiago FS, Luo X, et al. (2008) Angiotensin II-inducible platelet-derived growth factor-D transcription requires specific Ser/Thr residues in the second zinc finger region of Sp1. Circulation research 102: e38-51.
42. Irvine SA, Foka P, Rogers SA, Mead JR, Ramji DP (2005) A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages. Nucleic acids research 33: 1423-1434.
43. Lian H, Ma Y, Feng J, Dong W, Yang Q, et al. (2012) Heparin-binding EGFlike growth factor induces heart interstitial fibrosis via an Akt/mTor/p70s6k pathway. PloS one 7: e44946.
44. Liu N, Guo JK, Pang M, Tolbert E, Ponnusamy M, et al. (2012) Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis. Journal of the American Society of Nephrology: JASN 23: 854-867.
45. Dosanjh A (2012) The fibroblast growth factor pathway and its role in the pathogenesis of lung disease. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research 32: 111-114.
46. Masola V, Gambaro G, Tibaldi E, Brunati AM, Gastaldello A, et al. (2012) Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. The Journal of biological chemistry 287: 1478-1488.
47. Bonello MR, Khachigian LM (2004) Fibroblast growth factor-2 represses platelet-derived growth factor receptor-alpha (PDGFR-alpha) transcription via ERK1/2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-alpha promoter. The Journal of biological chemistry 279: 2377-2382.
48. Wang M, Bao YL, Wu Y, Yu CL, Meng XY, et al. (2010) Basic FGF downregulates TSP50 expression via the ERK/Sp1 pathway. Journal of cellular biochemistry 111: 75-81.